Opinion
Video
Author(s):
Neal Shore, MD, FACS, highlights the exciting advancements in radioligand therapy for prostate cancer, noting that ongoing trials are exploring its use in various disease stages and settings, and emphasizes the importance of reviewing the VISION and FORE trial publications for further insights.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.